Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 40
2006 373
2007 1006
2008 1897
2009 2830
2010 3969
2011 5264
2012 6158
2013 7561
2014 8654
2015 9869
2016 9430
2017 10196
2018 11907
2019 12841
2020 5058
Text availability
Article attribute
Article type
Publication date

Search Results

85,150 results
Results by year
Filters applied: . Clear all
Page 1
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Wang Y, et al. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Lancet. 2020. PMID: 32423584 Free PMC article. Clinical Trial.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Muñoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A; GS-US-540-5773 Investigators. Goldman JD, et al. N Engl J Med. 2020 May 27. doi: 10.1056/NEJMoa2015301. Online ahead of print. N Engl J Med. 2020. PMID: 32459919
Sustainability of Community-Based Specialized Mental Health Services in Five European Countries: Protocol for Five Randomized Controlled Trial-Based Health-Economic Evaluations Embedded in the RECOVER-E Program.
Wijnen BFM, Smit F, Uhernik AI, Istvanovic A, Dedovic J, Dinolova R, Nica R, Velickovski R, Wensing M, Petrea I, Shields-Zeeman L. Wijnen BFM, et al. JMIR Res Protoc. 2020 Jun 1;9(6):e17454. doi: 10.2196/17454. JMIR Res Protoc. 2020. PMID: 32476658 Free article.
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W. Zhu FC, et al. Lancet. 2020 May 22:S0140-6736(20)31208-3. doi: 10.1016/S0140-6736(20)31208-3. Online ahead of print. Lancet. 2020. PMID: 32450106 Free PMC article.
Screening for type 2 diabetes mellitus.
Peer N, Balakrishna Y, Durao S. Peer N, et al. Cochrane Database Syst Rev. 2020 May 29;5:CD005266. doi: 10.1002/14651858.CD005266.pub2. Cochrane Database Syst Rev. 2020. PMID: 32470201 Review.
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
Shitara K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Lee J, Saito K, Kawaguchi Y, Kamio T, Kojima A, Sugihara M, Yamaguchi K; DESTINY-Gastric01 Investigators. Shitara K, et al. N Engl J Med. 2020 May 29. doi: 10.1056/NEJMoa2004413. Online ahead of print. N Engl J Med. 2020. PMID: 32469182
Non-nutritive sweeteners for diabetes mellitus.
Lohner S, Kuellenberg de Gaudry D, Toews I, Ferenci T, Meerpohl JJ. Lohner S, et al. Cochrane Database Syst Rev. 2020 May 25;5:CD012885. doi: 10.1002/14651858.CD012885.pub2. Cochrane Database Syst Rev. 2020. PMID: 32449201 Review.
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Wang Y, Zhou F, Zhang D, Zhao J, Du R, Hu Y, Cheng Z, Gao L, Jin Y, Luo G, Fu S, Lu Q, Du G, Wang K, Lu Y, Fan G, Zhang Y, Liu Y, Ruan S, Liu W, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Wang Y, et al. Version 2. Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9. Trials. 2020. PMID: 32448345 Free PMC article. Clinical Trial.
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol.
Perotti C, Del Fante C, Baldanti F, Franchini M, Percivalle E, Vecchio Nepita E, Seminari E, De Silvestri A, Bruno R, Klersy C. Perotti C, et al. Intern Emerg Med. 2020 May 28. doi: 10.1007/s11739-020-02384-2. Online ahead of print. Intern Emerg Med. 2020. PMID: 32468508
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Abou-Alfa GK, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, Cleary JM, Catenacci DV, Borad MJ, Bridgewater J, Harris WP, Murphy AG, Oh DY, Whisenant J, Lowery MA, Goyal L, Shroff RT, El-Khoueiry AB, Fan B, Wu B, Chamberlain CX, Jiang L, Gliser C, Pandya SS, Valle JW, Zhu AX. Abou-Alfa GK, et al. Lancet Oncol. 2020 May 13:S1470-2045(20)30157-1. doi: 10.1016/S1470-2045(20)30157-1. Online ahead of print. Lancet Oncol. 2020. PMID: 32416072
85,150 results
Jump to page